TargetMol
Phosphonic acid, [(2R,3S)-3-methyloxiranyl]-, calcium salt (9CI) is an antibiotic, used for the treatment of urinary tract infections and intestinal infections caused by susceptible strains.
More Information
Supplier Page
TargetMol
Betaxolol is a cardioselective beta-blocker used in the treatment of hypertension. Betaxolol has not been linked to instances of clinically apparent drug induced liver injury.
More Information
Supplier Page
TargetMol
Ropivacaine hydrochloride is the hydrochloride salt of ropivacaine, a local anesthetic of the amide type with analgesic activity.
More Information
Supplier Page
TargetMol
Thioridazine, an antipsychotic drug, is used in the therapy of psychosis and schizophrenia and shows serotonin antagonism or D4 selectivity.
More Information
Supplier Page
TargetMol
Flurbiprofen is an anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
More Information
Supplier Page
TargetMol
Cinoxacin
200 mg
| Purity Not Available
TargetMol
Cinoxacin, an older synthetic antimicrobial, was related to the quinolone class of antibiotics. Its activity was similar to oxolinic acid and nalidixic acid.
More Information
Supplier Page
TargetMol
Betaxolol is a cardioselective beta-blocker used in the treatment of hypertension. Betaxolol has not been linked to instances of clinically apparent drug induced liver injury.
More Information
Supplier Page
TargetMol
PD0166285 is a potent Wee1 and Chk1 inhibitor with activity at nanomolar concentrations.PD0166285 is a novel G2 checkpoint abrogator.
More Information
Supplier Page
TargetMol
PD0166285 is a potent Wee1 and Chk1 inhibitor with activity at nanomolar concentrations.PD0166285 is a novel G2 checkpoint abrogator.
More Information
Supplier Page